Julianne Averill Strong Track Record Moves Her Into Leadership Position at Alveo Technologies

Seasoned Healthcare Financial Expert to Drive Strategic Growth for Diagnostic Tech Startup

Julianne Averill, CPA, as Chief Financial Officer. In this role, Ms. Averill will be responsible for leading all financial operations and implementing key business strategies to accelerate Alveo’s growth as the company advances its be.well™ platform, a point-of-care and at-home diagnostic tool currently under development.

“Julianne’s strong track record of driving results and accelerating growth comes at a critical time as the U.S. enters the twindemic COVID+flu season,” said Ron Chiarello, Ph.D., Chairman, CEO and Founder of Alveo. “As Alveo continues its initiative of bringing accurate, at-home testing solutions to market, Julianne’s strong financial expertise will be a valuable asset to the leadership team, ensuring we remain poised for long-term success.”

Julianne Averill brings over 18 years of leadership experience in the life sciences, technology/SaaS, and digital health fields as well as has participated in or led over $2B in successful strategic financing and M&A initiatives. Most recently, she served as Vice President of Finance for BlackThorn Therapeutics, driving strategic growth initiatives and investment strategies. Ms. Averill has held leadership roles at Manifest MedEx and Starwood Waypoint Residential Trust, where she successfully improved financial operations to support long-term company growth. She also served as an audit manager at Deloitte, working with various Fortune 500 and international entities in the consumer business and life sciences industries.

“I was instantly drawn to Alveo’s vision of putting an affordable, rapid at-home diagnostic tool for infectious diseases into the hands of consumers worldwide,” said Ms. Averill. “Alveo has a strong leadership team, a unique solution, and tremendous potential. I am thrilled to be joining the company at this exciting stage of its development. I look forward to leveraging my experience to help drive growth at Alveo as it continues on the trajectory of transforming the way infectious diseases are detected and managed.”

 

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version